Agenda
REVAMPING MICROBIOLOGICAL TEST METHODS FOR CONTACT LENSES, PRODUCTS, AND ACCESSORIES TO PROTECT HEALTH AND ENSURE SAFETY
AGENDA
FRIDAY, SEPTEMBER 12, 2014
7:30 AM - 5:00 PM
7:30 - 8:00
8:00 – 8:05
8:05 – 8:10
8:10 – 8:15
8:15 – 8:20
8:20 – 8:25
8:25 – 8:35
8:35 – 8:45
8:45 – 8:55
8:55 – 9:10
9:10 – 9:25
9:25 – 9:40
9:40 – 10:40
10:40 – 10:55
10:55 – 11:10
11:10 – 11:25
11:25 – 11:40
11:40 – 12:40
12:40 – 1:40
1:40 – 1:55
1:55 – 2:10
2:10 – 2:25
2:25 – 4:25
4:25 – 5:00
5:00
Meeting Materials Pick Up
Welcome & Goals – Food and Drug Administration (FDA)
Welcome – American Academy of Ophthalmology (AAO)
Welcome – American Academy of Optometry (AAOpt)
Welcome – American Optometric Association (AOA)
Welcome – Contact Lens Association of Ophthalmologists (CLAO)
Regulation of Contact Lenses and Associated Care Products
Preclinical Test Methods for Contact Lenses and their Care Products
History & Rationale for the Panel of Test Organisms for Contact Lens Care Products
PANEL 1: Emerging Pathogens in Contact Lens-Related Keratitis
Panelists: Suzi Fleiszig, OD, PhD, Michelle Callegan, PhD, Mark Willcox, PhD, Eduardo Alfonso, MD, Jennifer Cope, MD, MPH (CDC), Elmer Tu, MD, John Dart, MD
Causes of Contact Lens-Related Infectious Keratitis in the U.S.: Historical Trends and Emerging Pathogens
International Patterns of Contact Lens- Related Infectious Keratitis
Impact of Changing Water Restrictions on Contact Lens-Related Infectious Keratitis
Panel Discussion Question #1
BREAK
Panel 2: Role of Soil in Disinfection Efficacy Testing
Panelists: Carol Lakkis, PhD, Suzi Fleiszig, OD, PhD, Michelle Callegan, PhD, Mark Willcox, PhD, Ralph Stone, PhD
Definition of Organic Soil and the Relevant Components of an Artificial Tear Model
Incorporating Soil in the Preclinical Testing of Contact Lenses and their Products: Historical Perspective & Current Methods
Measuring the Efficacy of Organic Soil Removal
Panel Discussion Question #2
LUNCH
Panel 3: Acanthamoeba: The Organism and Test Methods
Panelists: Donald Ahearn, PhD, Simon Kilvington, PhD, Elmer Tu, MD, Ralph Stone, PhD, Mary Mowrey-McKee, PhD
Acanthamoeba Keratitis: Biology of the Organism and Host Factors (view slide presentation)
Disinfection Efficacy Test Methods for Acanthamoeba
Disinfection Efficacy Test Methods for Acanthamoeba
Panel Discussion Questions #3-5
Closing Remarks
CLAO
AOA
AAOpt
AAO
FDA
ADJOURN
Malvina Eydelman, MD
Thomas Steinemann, MD
Loretta Szczotka-Flynn, OD, PhD
Joseph Shovlin, OD
Deborah Jacobs, MD
Jeffrey Brocious, MS (FDA)
Moderator: Loretta Szczotka-Flynn, OD, PhD (AAO)
Moderator: Michael Dueñas, OD, (AOA)
Moderator: Deepinder Dhaliwal, MD
Daniel Fedorko, PhD (FDA)
Simon Kilvington, PhD
Loretta Szczotka-Flynn, OD, PhD
Thomas Steinemann, MD
Malvina Eydelman, MD